Acceptance and Commitment Therapy for Smoking Cessation in the Primary Care Setting (ACT)

October 26, 2017 updated by: Dr. Yim Wah Mak, The Hong Kong Polytechnic University

Individual, Telephone-delivered Acceptance and Commitment Therapy for Smoking Cessation in the Primary Healthcare Setting: Feasibility and Potential Efficacy

The purpose of this study is to evaluate the feasibility and potential efficacy of Acceptance and Commitment Therapy (ACT) in enhancing smoking cessation among attendees in primary healthcare settings.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The program is preventive and corrective, and carries brief messages by approaching and influencing services attendees who may not be able to reach in traditional reactive approach method of service users. Those traditional approaches are, for example, quitline and smoking cessation clinic. It can therefore benefit a larger population at low cost.

Study Type

Interventional

Enrollment (Actual)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hong Kong
    • Kowloon
      • Hung Hom, Kowloon, Hong Kong
        • School of Nursing, The Hong Kong Polytechnic University
    • New Territories
      • Tai Po, New Territories, Hong Kong
        • United Christian Nethersole Community Health Service, Kwong Fuk Community Health Centre
      • Tin Shui Wai, New Territories, Hong Kong
        • Heavenly Joy Family Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged 18 years and older
  • currently smoking at least one cigarette per day in the past 30 days
  • Hong Kong residents
  • able to communicate in Cantonese
  • currently residing in Hong Kong and expecting to continue to do so for the next 6 months
  • have access to a telephone

Exclusion Criteria:

  • currently undergoing another smoking cessation or similar program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
Participants are given printed self-help leaflet on smoking cessation developed by the Department of Health, Hong Kong.
Other: Control
Participants in the control group are provided a self-help leaflet on smoking cessation only
Other Names:
  • Control intervention
Experimental: Acceptance and Commitment Therapy
All participants are given a self-help leaflet on smoking cessation. Participants are also given an initial session of face-to-face ACT at a primary health service clinic. In addition, two more subsequent ACT sessions are provided by telephone at one week and one month after the initial intervention.
Behavioral: Acceptance and Commitment Therapy
All participants are given an initial smoking cessation session via face to face by Acceptance and Commitment Therapy. Two other sessions using the same therapy will be provided by telephone. The total contact time by ACT will be 45 mins (15 mins per session).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
7-day point prevalence by self report
Time Frame: at 6 months
self-reports on stopped smoking for a consecutive 7 days proceeding to the assessment at 6 months post-intervention
at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
validated self-report not smoking measured
Time Frame: at 6 months after the baseline
Obtaining CO measurement and testing urinary cotinine for those participants who report quitting smoking
at 6 months after the baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility outcomes
Time Frame: 1 year
Feasibility outcomes will be assessed in terms of participant recruitment, programme attendance and retention, their acceptance of physical cravings, emotions and thoughts related to smoking
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The Hong Kong Polytechnic University

Collaborators

Food and Health Bureau, Hong Kong

Investigators

  • Principal Investigator: YW Mak, PhD, School of Nursing, The Hong Kong Polytechnic University
  • Principal Investigator: AY Loke, PhD, School of Nursing, The Hong Kong Polytechnic University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

July 26, 2012

First Submitted That Met QC Criteria

July 26, 2012

First Posted (Estimate)

July 30, 2012

Study Record Updates

Last Update Posted (Actual)

October 30, 2017

Last Update Submitted That Met QC Criteria

October 26, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HHSRF9101421

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Control

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe